Navigation Links
Pharmaxis Reports Phase II Results for Aridol in COPD

tory Medicine: (2007) doi:10.1016/j.rmed.2007.01.08 4: Global initiative for chronic Obstructive Lung Disease (GOLD) 2006 ( http://www.goldcopd.com/ ) Forward-Looking Statements

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this press release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We can not guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors and Other Uncertainties" section of our Form 20-F lodged with the U.S. Securities and Exchange Commission.

    Released through:


    United States:

     Brandon Lewis, Trout Group

     Tel:   +1-646-378-2915

     Email: 


    Australia:

     Virginia Nicholls

     Tel:   +61-0-417-610-824

     Email: 


    CONTACT:


    Alan Robertson - Chief Executive Officer

     Tel:   +61-2-9454-7200

     Email: 

blewis@troutgroup.com virginia.nicholls@pharmaxis.com.au arobertson@pharmaxis.com.au

CONTACT: Alan Robertson, Chief Executive Officer of Pharmax
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pharmaxis Reports Phase Results for Aridol COPD
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ... Reputation of Pharma in 2014 - a Perspective of ... to their offering. For the first time, ... corporate reputation of the pharmaceutical industry held by patient ... views of patient organisations representing all therapy areas. ...
(Date:4/16/2015)... 2015 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... and commercialization of products for the treatment of central ... for the first quarter of 2015 on Wednesday, May ... The Company will host a conference call at 4:30 ... Vanda management will discuss the first quarter 2015 financial ...
(Date:4/16/2015)... -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will report results ... May 6, 2015, following the close of the U.S. financial ... and live webcast on the same day at 5:00 p.m. ... financial results.  To access the webcast via ... link.  Please log onto the webcast prior to the start ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
... of Americans who are obese will increase to 164 million, ... years, a recent study says. 1 800 GET THIN ... individuals suffering from obesity and associated diseases resulting from obesity. ... and professionals we work with, is to attain a healthier ...
... a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP), ... announce MusclePharm,s preliminary financial results for the third quarter ... basis, the Company expects unaudited gross revenues for the ... an increase of 305% as compared to gross revenues ...
Cached Medicine Technology:1-800-GET-THIN Agrees With Report Calling for Better Eating Habits 2MusclePharm Announces Preliminary Third Quarter 2011 Results 2MusclePharm Announces Preliminary Third Quarter 2011 Results 3
(Date:4/18/2015)... (PRWEB) April 18, 2015 Patients who ... of developing mesothelioma later in life, but the disease ... mesothelioma that is unrelated to radiation. Surviving Mesothelioma has ... its website. Click here to read it now. ... compared the cases of 45 patients who had both ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released Volume ... say, “exposes a tactical shift by cyberattackers.” With everything from ... in 2014 - almost a million a day - to ... identified and patched by prominent manufacturers – as long as ... in a digital world can be fraught with peril, and ...
(Date:4/18/2015)... 18, 2015 French physician and gastronome ... choices when he uttered, “Tell me what you eat, ... food to cope with stress or sadness has often ... indicates otherwise. Data collected from their Emotional ... to emotional eating, but for different reasons. , Collecting ...
(Date:4/17/2015)... Lynnwood, WA (PRWEB) April 17, 2015 ... seat cushions is introducing two new products to help ... seeking low back pain relief are the second most ... was our first product, designed specifically to help relieve ... the Comfort Cushion, and thousands of happy customers later, ...
(Date:4/17/2015)... have seen healing, a lot of healing, and a lot ... Kafader of Friendship Village. “People have found purpose. ... have created beautiful pieces of art.” For the past eight ... was launched to benefit residents of the retirement community. , ... Institute in Chicago, worked as an intern at Friendship Village, ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Healing At Friendship Village Due To Art Therapy 2
... to 20 percent of people infected with HIV, the ... into the brain, resulting in HIV-associated dementia and other ... of Medicine of Yeshiva University have found strong evidence ... bacteriaa chemical present in high levels in the blood ...
... Quarterly Reports use Market Intelligence and Competitive Analysis ... the Pharmaceutical Pipeline, LONDON and PHILADELPHIA, Aug. ... intelligent information for businesses and,professionals, has announced the ... period January-March 2008. Launched more than two years,ago, ...
... many commonly used ... prescription medications, FRANKLIN LAKES, N.J., Aug. ... leading pharmacy benefit manager,announced it and the Food and Drug Administration ... the impact of genetics on,the efficacy of prescription drugs. The announcement ...
... of new study say aim is to generate awareness of ... trauma patients are less likely to be transported to an ... new study found. , The finding was based on a ... services (EMS) records. And it suggests that the difference in ...
... has,completed construction and received licensing from the Arizona ... Unit (ICU) and officially,opened August 13th, 2008. The ... the,following Saturday. Construction of Gilbert Hospital,s three-bed ICU ... The ICU is located in a,remodeled area of ...
... (VA) will open three Veterans Rural Health Resource,Centers on ... veterans and,develop special practices and products to implement across ... areas, the nearest medical center can,be miles away," said ... provide the best quality care to veterans regardless of ...
Cached Medicine News:Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 2Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 3Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 4Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 2Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 3Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 2Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 3Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 4Health News:Older Patients Less Likely to Be Taken to Trauma Centers 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 3Health News:New Intensive Care Unit at Gilbert Hospital Sees First Patient 2
... provides the adaptability surgeons need to make ... other way around. The wide selection of ... components allow surgeons to address the unexpected ... all with one instrument set. For cruciate ...
... knee manufacturers focus attention on implant design, ... The Profix Total Knee System seeks to ... implant system and the tools to implant ... widely recognized for innovation in total knee ...
Cemented hip system...
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
Medicine Products: